Kilitch Drugs (India) Limited has informed the Exchange that the Board of Directors at its meeting held on February 11, 2026, have considered and approved bonus at the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held.
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Kilitch Drugs (India) Limited, at its meeting held on February 11, 2026, approved a bonus issue of equity shares in the ratio of 1:1. This means shareholders will receive 1 bonus equity share for every 1 equity share they currently hold, effectively doubling the number of shares outstanding. The record date and other key details are expected to be announced separately by the company.
A 1:1 bonus issue increases the share count and typically reduces the stock price proportionally on the ex-date, with no change in overall market value for existing shareholders. It is generally viewed as a positive signal of management confidence but is not above the 1:1 threshold that would mark an exceptional bonus.